Neuchatel, Switzerland

Andrea Wohlsen


 

Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Constance, DE (2009 - 2010)
  • Neuchatel, CH (2012 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Andrea Wohlsen: Innovator in Pharmaceutical Research

Introduction

Andrea Wohlsen is a prominent inventor based in Neuchatel, Switzerland. She has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for inflammatory diseases. With a total of six patents to her name, Wohlsen's work has had a considerable impact on medical science.

Latest Patents

Wohlsen's latest patents include innovative approaches to treating inflammatory pulmonary diseases. One notable invention is the combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors. This invention focuses on the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the prevention and curative treatment of inflammatory pulmonary diseases. Another significant patent involves pyrazolone derivatives as PDE4 inhibitors. The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is recognized as a novel effective inhibitor of type 4 phosphodiesterase, useful in treating psoriasis or atopic dermatitis.

Career Highlights

Throughout her career, Wohlsen has worked with notable companies in the pharmaceutical industry, including Nycomed GmbH and Takeda GmbH. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Wohlsen has collaborated with esteemed colleagues such as Degenhard Marx and Armin Hatzelmann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Andrea Wohlsen is a trailblazer in the pharmaceutical industry, with a focus on developing innovative treatments for inflammatory diseases. Her contributions through her patents and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…